{"id":"https://openalex.org/W2140725933","doi":"https://doi.org/10.4088/jcp.14m09689","title":"Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study","display_name":"Adjunctive Brexpiprazole 1 and 3 mg for Patients With Major Depressive Disorder Following Inadequate Response to Antidepressants: A Phase 3, Randomized, Double-Blind Study","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-03","ids":{"openalex":"https://openalex.org/W2140725933","doi":"https://doi.org/10.4088/jcp.14m09689","mag":"2140725933","pmid":"https://pubmed.ncbi.nlm.nih.gov/26301771"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.14m09689","doi":"https://doi.org/10.4088/jcp.14m09689","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.14m09689","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2140725933"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085107940","display_name":"Michael E. Thase","orcid":"https://orcid.org/0000-0002-6403-0861","observed_orcids":["https://orcid.org/0000-0002-6403-0861","https://orcid.org/0009-0002-3646-845X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael E. Thase","raw_affiliation_strings":["Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, 3535 Market St, Philadelphia, PA 19104 thase@mail.med.upenn.edu","Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, 3535 Market St, Philadelphia, PA 19104"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, 3535 Market St, Philadelphia, PA 19104 thase@mail.med.upenn.edu","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, 3535 Market St, Philadelphia, PA 19104","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087611468","display_name":"James M. Youakim","orcid":"https://orcid.org/0000-0001-5551-8956","observed_orcids":["https://orcid.org/0000-0001-5551-8956"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Youakim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021739236","display_name":"Aleksandar Skuban","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleksandar Skuban","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110533970","display_name":"Mary Hobart","orcid":"https://orcid.org/0009-0006-0216-1483","observed_orcids":["https://orcid.org/0009-0006-0216-1483"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Hobart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005720083","display_name":"Peter G. Y. Zhang","orcid":"https://orcid.org/0000-0003-0557-3572","observed_orcids":["https://orcid.org/0000-0003-0557-3572"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108358185","display_name":"Robert D. McQuade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert D. McQuade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026852397","display_name":"Margaretta Nyilas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaretta Nyilas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036492697","display_name":"William H. Carson","orcid":"https://orcid.org/0000-0002-8876-9556","observed_orcids":["https://orcid.org/0000-0002-8876-9556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William H. Carson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045081626","display_name":"Raymond Sanchez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond Sanchez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103127258","display_name":"Hans Eriksson","orcid":"https://orcid.org/0000-0002-1799-289X","observed_orcids":["https://orcid.org/0000-0002-1799-289X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans Eriksson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085107940"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":11.8247,"has_fulltext":false,"cited_by_count":186,"citation_normalized_percentile":{"value":0.99399638,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"76","issue":"09","first_page":"1232","last_page":"1240"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brexpiprazole","display_name":"brexpiprazole","score":0.9950000047683716},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9750000238418579},{"id":"https://openalex.org/keywords/inadequate-response-to-antidepressants","display_name":"inadequate response to antidepressants","score":0.7670000195503235},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8360000252723694},{"id":"https://openalex.org/keywords/akathisia","display_name":"akathisia","score":0.6859999895095825},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.5789999961853027},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.6420000195503235},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.40799999237060547},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.43700000643730164},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.5009999871253967},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.45899999141693115},{"id":"https://openalex.org/keywords/montgomery-asberg-depression-rating-scale","display_name":"Montgomery-Asberg Depression Rating Scale","score":0.765999972820282},{"id":"https://openalex.org/keywords/sheehan-disability-scale","display_name":"Sheehan Disability Scale","score":0.9760000109672546}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7914155125617981},{"id":"https://openalex.org/C2777393122","wikidata":"https://www.wikidata.org/wiki/Q416417","display_name":"Akathisia","level":4,"score":0.6733596920967102},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6200068593025208},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.598535418510437},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5706526637077332},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.506442666053772},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4916916489601135},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.47987595200538635},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.45018139481544495},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.38390833139419556},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3620482087135315},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.27592962980270386},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.24657905101776123},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1094086766242981},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2779144063","wikidata":"https://www.wikidata.org/wiki/Q338924","display_name":"Amygdala","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015363","descriptor_name":"Quinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061218","descriptor_name":"Depressive Disorder, Treatment-Resistant","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.14m09689","doi":"https://doi.org/10.4088/jcp.14m09689","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.14m09689","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:26301771","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26301771","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W141566299","https://openalex.org/W590310416","https://openalex.org/W1488179480","https://openalex.org/W1854929367","https://openalex.org/W1868790909","https://openalex.org/W1940295429","https://openalex.org/W1992123212","https://openalex.org/W1993810702","https://openalex.org/W1998648170","https://openalex.org/W1999689270","https://openalex.org/W2000053835","https://openalex.org/W2007880575","https://openalex.org/W2012655610","https://openalex.org/W2020739757","https://openalex.org/W2046186483","https://openalex.org/W2051198709","https://openalex.org/W2051453284","https://openalex.org/W2061378977","https://openalex.org/W2064476618","https://openalex.org/W2069138677","https://openalex.org/W2078154303","https://openalex.org/W2104518967","https://openalex.org/W2111663098","https://openalex.org/W2114613490","https://openalex.org/W2131823335","https://openalex.org/W2148083007","https://openalex.org/W2151839057","https://openalex.org/W2160070901","https://openalex.org/W2165379748","https://openalex.org/W2167761850","https://openalex.org/W2171340584","https://openalex.org/W2189057525","https://openalex.org/W2225684373","https://openalex.org/W2340538438","https://openalex.org/W2341173628","https://openalex.org/W2399110179"],"related_works":["https://openalex.org/W1868790909","https://openalex.org/W2803445534","https://openalex.org/W2789214860","https://openalex.org/W2911295141","https://openalex.org/W2957698583","https://openalex.org/W2965463967","https://openalex.org/W4414895110","https://openalex.org/W4388457329","https://openalex.org/W2560018769","https://openalex.org/W1979218784"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"efficacy,":[3],"safety,":[4],"and":[5,119,154,248,258,279],"tolerability":[6],"of":[7,42,114,132,320],"brexpiprazole":[8,52,55,165,191,206,255,298,321],"adjunctive":[9],"to":[10,28,50,80],"antidepressant":[11],"treatments":[12],"(ADTs)":[13],"in":[14,70,91,175,211,254,266,311],"patients":[15,108,135],"with":[16,25,117,297],"major":[17],"depressive":[18],"disorder":[19],"(as":[20],"defined":[21],"by":[22,39],"DSM-IV-TR":[23],"criteria)":[24],"inadequate":[26,140],"response":[27,141],"ADTs.":[29],"METHOD:":[30],"Patients":[31],"still":[32],"depressed":[33],"despite":[34],"1-3":[35],"prior":[36],"ADTs":[37],"followed":[38],"8":[40],"weeks":[41],"prospective":[43,145],"physician-determined,":[44],"open-label":[45],"ADT":[46],"were":[47,239,294,322],"randomized":[48],"(1:1:1)":[49],"double-blind":[51],"3":[53,166,299,305],"mg/d,":[54,57],"1":[56,112,121,192],"or":[58],"placebo":[59,180,216,259,310],"for":[60,101,139],"6":[61],"weeks.":[62],"The":[63,83,97,103,147,205,234],"primary":[64],"efficacy":[65,86,104,126,133,160,308,313],"end":[66,87],"point":[67,88],"was":[68,89,149],"change":[69,90],"Montgomery-Asberg":[71],"Depression":[72],"Rating":[73,282],"Scale":[74,94,270,283],"(MADRS)":[75],"total":[76,177,292],"score":[77,178,214],"from":[78,264],"baseline":[79,118,265],"week":[81],"6.":[82],"key":[84],"secondary":[85],"Sheehan":[92],"Disability":[93],"mean":[95,213,220,272,285],"score.":[96],"Hochberg":[98],"procedure":[99],"corrected":[100],"multiplicity.":[102],"population":[105,127,134,161,314],"comprised":[106],"all":[107],"who":[109],"had":[110],"\u2265":[111,120],"dose":[113],"study":[115,148],"drug":[116],"postrandomization":[122],"MADRS":[123,176],"scores;":[124],"the":[125,143,159,312],"per":[128,162,315],"final":[129,163,316],"protocol":[130],"consisted":[131],"meeting":[136],"amended":[137],"criteria":[138],"throughout":[142],"8-week":[144],"ADT.":[146],"conducted":[150],"between":[151],"June":[152],"2011":[153],"September":[155],"2013.":[156],"RESULTS:":[157],"In":[158],"protocol,":[164],"mg":[167,193,300,306],"(n":[168,181,196],"=":[169,182,188,197,203,226,232,274,277,287,290],"213)":[170],"showed":[171,208],"a":[172],"greater":[173,296],"improvement":[174,210],"versus":[179,215,301,309],"203;":[183],"-8.29":[184],"vs":[185,200],"-6.33;":[186,201],"P":[187,202,225,231,276,289],".0079),":[189],"whereas":[190],"did":[194],"not":[195],"211;":[198],"-7.64":[199],".0737).":[204],"groups":[207],"comparable":[209],"SDS":[212],"(least":[217],"squares":[218],"[LS]":[219],"difference:":[221],"[1":[222],"mg]":[223,229],"-0.49,":[224],".0158;":[227],"[3":[228],"-0.48,":[230],".0191).":[233],"most":[235],"frequent":[236],"adverse":[237],"events":[238],"akathisia":[240],"(4.4%,":[241],"13.5%,":[242],"2.3%),":[243],"headache":[244],"(9.3%,":[245],"6.1%,":[246],"7.7%),":[247],"weight":[249],"increase":[250],"(6.6%,":[251],"5.7%,":[252],"0.9%)":[253],"1-mg,":[256],"3-mg,":[257],"groups,":[260],"respectively.":[261],"Mean":[262],"changes":[263],"Abnormal":[267],"Involuntary":[268],"Movement":[269],"(LS":[271,284],"difference":[273,286],"0.08,":[275],".0141)":[278],"Barnes":[280],"Akathisia":[281],"0.17,":[288],".0001)":[291],"scores":[293],"significantly":[295],"placebo.":[302],"CONCLUSIONS:":[303],"Brexpiprazole":[304],"demonstrated":[307],"protocol.":[317],"Both":[318],"doses":[319],"well":[323],"tolerated.":[324],"TRIAL":[325],"REGISTRATION:":[326],"ClinicalTrials.gov":[327],"identifier:":[328],"NCT01360632.":[329]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2140725933","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":16},{"year":2019,"cited_by_count":15},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":27},{"year":2015,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
